Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX - F. Ciardiello, N. Normanno, E. Martinelli, T. Troiani, S. Pisconti, C. Cardone, A. Nappi, A. R. Bordonaro, M. Rachiglio, M. Lambiase, T. P. Latiano, G. Modoni, S. Cordio, F. Giuliani, M. Biglietto - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

Published in

Elsevier, Annals of Oncology, 6(27), p. 1055-1061, 2016

DOI: 10.1093/annonc/mdw136

Links

Tools

Export citation

Search in Google Scholar

Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX

Journal article published in 2016 by F. Ciardiello, N. Normanno, E. Martinelli, T. Troiani, S. Pisconti, C. Cardone, A. Nappi, A. R. Bordonaro, M. Rachiglio, M. Lambiase, T. P. Latiano, G. Modoni, S. Cordio, F. Giuliani, M. Biglietto and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO